Relaxation therapy studied for brain tumor anxiety – but trial cut short

NCT ID NCT05189366

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tested whether adding sophrology (a relaxation method using breathing, visualization, and gentle movement) to speech therapy could reduce anxiety in people with aggressive brain tumors. Only 13 patients were enrolled before the trial was stopped early. The goal was to see if this combination improved anxiety levels and quality of life compared to speech therapy alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIAL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, 44805, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

sophrology (relaxation therapy)

What this could lead to

If it had worked, this approach could have offered a simple, drug-free way to reduce anxiety and improve quality of life for brain tumor patients with speech difficulties.

What could go wrong

The trial was terminated early and enrolled only 13 people, so results are very limited. It is unclear if sophrology provides any real benefit over standard care.

Conditions

The condition(s) this trial relates to.

communication disorder glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.